The peel of Hylocereus polyrhizus is often regarded as a waste hence this study was aimed at exploring the feasibility of using the peel as a natural colorant using simple water extraction method. Samples were subjected to a series of temperatures: Room temperature (RT), 50, 80 and 100 degrees C; varied length of heating time from 1, 2, 3, 4, 5 and 10 min and a varied range of pH using 1 M of citric acid solution. The best condition to obtain highest betacyanin content was heating samples at 100 degrees C for 5 min in a pH 5 citric acid solution. The next part of this study involved the stability test of the pigments obtained through the best method determined earlier. The pigments were dried and resuspended in distilled water. The samples were then exposed to light to monitor pigment changes. Initial resuspension of the dried pigments yielded a comparable high content of betacyanins to its juice counterpart. The results showed that resuspended pigments had high pigment retention and were stable up to 7 days. These initial findings must be further studied in more controlled conditions to understand the stability of betacyanin. Nevertheless, the results show that betacyanin obtained from the peel of dragon fruit has a high potential to be used as a natural dye.
Anti-cancer drug loaded-nanoparticles (NPs) or encapsulation of NPs in colon-targeted delivery systems shows potential for increasing the local drug concentration in the colon leading to improved treatment of colorectal cancer. To investigate the potential of the NP-based strategies for colon-specific delivery, two formulations, free Eudragit® NPs and enteric-coated NP-loaded chitosan-hypromellose microcapsules (MCs) were fluorescently-labelled and their tissue distribution in mice after oral administration was monitored by multispectral small animal imaging. The free NPs showed a shorter transit time throughout the mouse digestive tract than the MCs, with extensive excretion of NPs in faeces at 5h. Conversely, the MCs showed complete NP release in the lower region of the mouse small intestine at 8h post-administration. Overall, the encapsulation of NPs in MCs resulted in a higher colonic NP intensity from 8h to 24h post-administration compared to the free NPs, due to a NP 'guarding' effect of MCs during their transit along mouse gastrointestinal tract which decreased NP excretion in faeces. These imaging data revealed that this widely-utilised colon-targeting MC formulation lacked site-precision for releasing its NP load in the colon, but the increased residence time of the NPs in the lower gastrointestinal tract suggests that it is still useful for localised release of chemotherapeutics, compared to NP administration alone. In addition, both formulations resided in the stomach of mice at considerable concentrations over 24h. Thus, adhesion of NP- or MC-based oral delivery systems to gastric mucosa may be problematic for colon-specific delivery of the cargo to the colon and should be carefully investigated for a full evaluation of particulate delivery systems.